Oregon v. ACE Holdings, Inc.

Consent decrees filed by states in state court required $4.5 million payment and conduct relief to remedy alleged bid-rigging and false insurance quotes, as well as payment of secret “contingent commissions” to brokers.

Read More →

District of Columbia v. ACE Holdings, Inc.

Consent decrees filed by states in state court required $4.5 million payment and conduct relief to remedy alleged bid-rigging and false insurance quotes, as well as payment of secret “contingent commissions” to brokers.

Read More →

Texas v. ACE Holdings, Inc.

Consent decrees filed by states in state court required $4.5 million payment and conduct relief to remedy alleged bid-rigging and false insurance quotes, as well as payment of secret “contingent commissions” to brokers.

Read More →

Florida v. ACE Holdings, Inc.

Consent decrees filed by states in state court required $4.5 million payment and conduct relief to remedy alleged bid-rigging and false insurance quotes, as well as payment of secret “contingent commissions” to brokers.

Read More →

West Virginia ex rel. McGraw v. Visa USA, Inc. et al., No. 03-C-551 (Cir. Ct. Ohio Cty. 2003)

The State sued Visa and Mastercard claiming the companies used their market power in general credit cards to force merchants to accept their branded debit cards. The high cost of accepting the branded debit cards forced retailers to charge consumers more for goods purchased. As a settlement, Visa paid $9.3 million and MasterCard paid $2.3 million to state, which was used to fund a tax holiday on Energy Star products, and a total of $600,000 to the Attorney General’s revolving fund.

Read More →

West Virginia ex rel. McGraw v. GlaxoSmithKline, PLC et al., No. 04-C-254M (Cir. Ct. Marshall Cty. 2004)

Plaintiff state filed a lawsuit and consent order to settle the lawsuit against GlaxoSmithKline, PLC, and SmithKline Beechham Corporation, the manufacturers of the prescription drugs, Paxil, Augmentin, and Relafen. Paxil is commonly prescribed for anxiety and depression, Augmentin is an antibiotic, and Relafen is a non-steroidal pain reliever. The State alleged that the defendants had unlawfully attempted to extend their patent protection for the three prescription drugs. After an investigation, the State reached an agreement with the defendants to settle the manner. Under the terms of the settlement, the State received $500,000.00.

Read More →

West Virginia ex rel. McGraw v. Mid-American Waste Systems of West Virginia, Inc., No. 97-C-255 (Cir. Ct. Wood Cty. 1997)

Owner of only landfillin area sought to monopolize market by use of evergreen contracts

Read More →

Archer v. Hoffmann-La Roche, Ltd., Roche Vitamins Inc., Aventis Animal Nutrition S.A.; Daiichi Pharmaceutical Co., LTD.; Eisai Co., Ltd; Takeda Chemical Industries, LTD., and Basf Corporation

State intervened in private class action suit following guilty pleas by vitamin manufacturers.

Read More →

West Virginia ex rel. McGraw v. Kimberly-Clark Corporation, et al., No. 99-C-2349 (Cir. Ct. Kanawha Cty. 2000)

Suit alleged price-fixing in the commercial tissue paper market. After dismissal from federal court, state refiled in state court and parties reached a settlement.

Read More →

West Virginia ex rel. Tompkins v. Northwestern Disposal Co. et al., No. 90-C-130 (Cir. Ct. Wood Cty. 1990).

Case alleged monopolization by owner of only landfill within geographic area.

Read More →